-
Je něco špatně v tomto záznamu ?
Quantitative Biology of Human Shelterin and Telomerase: Searching for the Weakest Point
P. Veverka, T. Janovič, C. Hofr,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, přehledy
Grantová podpora
16-20255S, 19-18226S
Grantová Agentura České Republiky
CEITEC 2020 (LQ1601)
Ministry of Education, Youth and Sports of the Czech Republic
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
PubMed Central
od 2007
Europe PubMed Central
od 2007
ProQuest Central
od 2000-03-01
Open Access Digital Library
od 2000-01-01
Open Access Digital Library
od 2007-01-01
Health & Medicine (ProQuest)
od 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
PubMed
31261825
DOI
10.3390/ijms20133186
Knihovny.cz E-zdroje
- MeSH
- inhibitory enzymů farmakologie MeSH
- lidé MeSH
- proteiny vázající telomery chemie metabolismus MeSH
- protinádorové látky farmakologie MeSH
- telomerasa antagonisté a inhibitory chemie metabolismus MeSH
- vazba proteinů MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The repetitive telomeric DNA at chromosome ends is protected from unwanted repair by telomere-associated proteins, which form the shelterin complex in mammals. Recent works have provided new insights into the mechanisms of how human shelterin assembles and recruits telomerase to telomeres. Inhibition of telomerase activity and telomerase recruitment to chromosome ends is a promising target for anticancer therapy. Here, we summarize results of quantitative assessments and newly emerged structural information along with the status of the most promising approaches to telomerase inhibition in cancer cells. We focus on the mechanism of shelterin assembly and the mechanisms of how shelterin affects telomerase recruitment to telomeres, addressing the conceptual dilemma of how shelterin allows telomerase action and regulates other essential processes. We evaluate how the identified critical interactions of telomerase and shelterin might be elucidated in future research of new anticancer strategies.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19044704
- 003
- CZ-PrNML
- 005
- 20200113081217.0
- 007
- ta
- 008
- 200109s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms20133186 $2 doi
- 035 __
- $a (PubMed)31261825
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Veverka, Pavel $u LifeB, Chromatin Molecular Complexes, CEITEC and Functional Genomics and Proteomics, National Centre for Biomolecular Research, Faculty of Science, Masaryk University, CZ-62500 Brno, Czech Republic.
- 245 10
- $a Quantitative Biology of Human Shelterin and Telomerase: Searching for the Weakest Point / $c P. Veverka, T. Janovič, C. Hofr,
- 520 9_
- $a The repetitive telomeric DNA at chromosome ends is protected from unwanted repair by telomere-associated proteins, which form the shelterin complex in mammals. Recent works have provided new insights into the mechanisms of how human shelterin assembles and recruits telomerase to telomeres. Inhibition of telomerase activity and telomerase recruitment to chromosome ends is a promising target for anticancer therapy. Here, we summarize results of quantitative assessments and newly emerged structural information along with the status of the most promising approaches to telomerase inhibition in cancer cells. We focus on the mechanism of shelterin assembly and the mechanisms of how shelterin affects telomerase recruitment to telomeres, addressing the conceptual dilemma of how shelterin allows telomerase action and regulates other essential processes. We evaluate how the identified critical interactions of telomerase and shelterin might be elucidated in future research of new anticancer strategies.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a protinádorové látky $x farmakologie $7 D000970
- 650 _2
- $a inhibitory enzymů $x farmakologie $7 D004791
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a telomerasa $x antagonisté a inhibitory $x chemie $x metabolismus $7 D019098
- 650 _2
- $a proteiny vázající telomery $x chemie $x metabolismus $7 D034501
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Janovič, Tomáš $u LifeB, Chromatin Molecular Complexes, CEITEC and Functional Genomics and Proteomics, National Centre for Biomolecular Research, Faculty of Science, Masaryk University, CZ-62500 Brno, Czech Republic.
- 700 1_
- $a Hofr, Ctirad $u LifeB, Chromatin Molecular Complexes, CEITEC and Functional Genomics and Proteomics, National Centre for Biomolecular Research, Faculty of Science, Masaryk University, CZ-62500 Brno, Czech Republic. hofr@sci.muni.cz.
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 20, č. 13 (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31261825 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200113081549 $b ABA008
- 999 __
- $a ok $b bmc $g 1482973 $s 1083377
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 20 $c 13 $e 20190628 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a 16-20255S, 19-18226S $p Grantová Agentura České Republiky
- GRA __
- $a CEITEC 2020 (LQ1601) $p Ministry of Education, Youth and Sports of the Czech Republic
- LZP __
- $a Pubmed-20200109